Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Obesity 3 Triple Negative Breast Neoplasms 2 Weight Gain 1 Stage IV Breast Cancer AJCC v6 and v7 1 Prostatic Neoplasms 1 Patient Compliance 1 Overweight 1 Ovarian Neoplasms 1 Motor Activity 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Fatigue 1 Endometrial Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

Anastrozole 2 beta-Aminoethyl Isothiourea 1 Trastuzumab 1 Surveys and Questionnaires 1 Specimen Handling 1 Nutrition Assessment 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Motivational Interviewing 1 Leuprolide 1 Lapatinib 1 Interviews as Topic 1 Goserelin 1 Exercise 1 Diet Therapy 1 Clodronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Diet Therapy × Breast × Clear all

NCT06635005 2026-05-11

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Completed

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡